Technical Analysis of Interventions for More Affordable Malaria Drugs
Artemisinin Combination Therapies (ACTs), the recommended treatment for malaria, remain unaffordable to large segments of populations in malaria endemic countries. ACTs were scaled up through financing from the Global Fund to Fight AIDS, Tuberculosis and Malaria, the US President’s Malaria Initiative and through the Affordable Medicines Facility for malaria (AMFm). A deeper understanding of the markets for manufacturing and distributing ACTs is critical to ensure the appropriate market interventions to make ACTs more affordable are enacted. WDI uses technical analysis to advise multiple stakeholders on intervention strategies, methods to match supply and demand, and policy levers that can create more affordable ACTs.